[go: up one dir, main page]

UY32316A - Derivados de piperidina utiles en el tratamiento de infecciones bacterianas - Google Patents

Derivados de piperidina utiles en el tratamiento de infecciones bacterianas

Info

Publication number
UY32316A
UY32316A UY0001032316A UY32316A UY32316A UY 32316 A UY32316 A UY 32316A UY 0001032316 A UY0001032316 A UY 0001032316A UY 32316 A UY32316 A UY 32316A UY 32316 A UY32316 A UY 32316A
Authority
UY
Uruguay
Prior art keywords
treatment
bacterial infections
piperidine derivatives
useful
useful piperidine
Prior art date
Application number
UY0001032316A
Other languages
English (en)
Inventor
Shahul Hameed Peer Mohamed
Waterson David
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY32316A publication Critical patent/UY32316A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen compuestos de fórmula (I) y sus sales farmacéuticamente aceptables. Se describen también procesos para su preparación, composiciones farmacéuticas que los contienen, su uso como medicamentos y su uso en el tratamiento de infecciones bacterianas.
UY0001032316A 2008-12-12 2009-12-11 Derivados de piperidina utiles en el tratamiento de infecciones bacterianas UY32316A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12194708P 2008-12-12 2008-12-12

Publications (1)

Publication Number Publication Date
UY32316A true UY32316A (es) 2010-07-30

Family

ID=41796516

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032316A UY32316A (es) 2008-12-12 2009-12-11 Derivados de piperidina utiles en el tratamiento de infecciones bacterianas

Country Status (13)

Country Link
US (1) US20120022107A1 (es)
EP (1) EP2379545A1 (es)
JP (1) JP2012511562A (es)
KR (1) KR20110094305A (es)
CN (1) CN102245603A (es)
AR (1) AR074721A1 (es)
AU (1) AU2009326143A1 (es)
BR (1) BRPI0923324A2 (es)
CA (1) CA2745725A1 (es)
MX (1) MX2011005841A (es)
TW (1) TW201026694A (es)
UY (1) UY32316A (es)
WO (1) WO2010067125A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103274984B (zh) * 2013-06-03 2016-08-24 四川铂瑞生物医药有限公司 一种5-甲基-吡咯-2甲酸乙酯的制备方法
US10399968B2 (en) 2015-09-30 2019-09-03 Daiichi Sankyo Company, Limited Hydroxyalkyl thiadiazole derivatives
JP2020511457A (ja) 2017-03-14 2020-04-16 第一三共株式会社 ヒドロキシアルキルチアジアゾール誘導体のｎ−ホスホノキシメチルプロドラッグ
EP3604281A4 (en) 2017-03-24 2020-08-19 Taisho Pharmaceutical Co., Ltd. 2(1h)-quinolinone derivative
EP3762369B1 (en) * 2018-03-06 2024-12-11 UPL Ltd A process for preparation of fungicidally active triazole compounds
WO2020048949A1 (en) 2018-09-03 2020-03-12 Univerza V Ljubljani New class of dna gyrase and/or topoisomerase iv inhibitors with activity against gram-positive and gram-negative bacteria
WO2022129327A1 (en) 2020-12-17 2022-06-23 Univerza V Ljubljani New n-phenylpyrrolamide inhibitors of dna gyrase and topoisomerase iv with antibacterial activity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW538046B (en) 1998-01-08 2003-06-21 Hoechst Marion Roussel Inc Aromatic amides having antiobiotic activities and the preparation processes, intermediates and pharmaceutical composition thereof
DK1251848T3 (da) 2000-01-18 2004-10-18 Vertex Pharma Gyraseinhibitorer og anvendelse deraf
EP1341769B1 (en) 2000-12-15 2007-10-17 Vertex Pharmaceuticals Incorporated Bacterial gyrase inhibitors and uses thereof
TW200526626A (en) * 2003-09-13 2005-08-16 Astrazeneca Ab Chemical compounds
KR20070113233A (ko) 2005-02-18 2007-11-28 아스트라제네카 아베 항균성 피페리딘 유도체
TW200819437A (en) * 2006-08-17 2008-05-01 Astrazeneca Ab Chemical compounds
TW200906412A (en) * 2007-06-12 2009-02-16 Astrazeneca Ab Piperidine compounds and uses thereof
TW201026695A (en) * 2008-12-12 2010-07-16 Astrazeneca Ab Piperidine compounds and uses thereof-596

Also Published As

Publication number Publication date
WO2010067125A1 (en) 2010-06-17
CN102245603A (zh) 2011-11-16
CA2745725A1 (en) 2010-06-17
AU2009326143A1 (en) 2011-06-30
AR074721A1 (es) 2011-02-09
JP2012511562A (ja) 2012-05-24
KR20110094305A (ko) 2011-08-23
EP2379545A1 (en) 2011-10-26
US20120022107A1 (en) 2012-01-26
MX2011005841A (es) 2011-06-17
BRPI0923324A2 (pt) 2017-07-11
TW201026694A (en) 2010-07-16

Similar Documents

Publication Publication Date Title
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
CR11641A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211
UY30759A1 (es) Compuestos quimicos
UY32315A (es) Compuestos de piperidina y usos de los mismo-596
UY31141A1 (es) Compuestos de piperidina y sus usos
UY31860A (es) Piridinas de tiazolo como inhibidoras de la adn girasa
UY30544A1 (es) Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones
UY31481A1 (es) Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones
CO6382176A2 (es) Derivados de urea heterociclicos y metodos de uso de los mismos-332
SV2010003451A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
UY32203A (es) Amino pirimidinas y su uso en terapia
UY31069A1 (es) Nuevos derivados de imidazoquinola, composiciones conteniendolos, proceso de preparacion y aplicaciones
DOP2010000374A (es) Derivados heterociclicos de la urea y sus metodos de empleo
DOP2011000203A (es) Derivados de pirimidin indol para el tratamiento de cancer
UY29384A1 (es) Derivados del ácido2-3s,4r)-4-(((3,4-dicloro-5-metil-1h-pirrol-2-il) carbonil)amino)-1,3-tiazol-5-carboxílico y sus sales, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciónes.
ECSP109856A (es) Derivados de oxadiazol y su uso como potenciadores de los receptores metabotrópicos de glutamato - 842
CL2011000589A1 (es) Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer.
ECSP10010693A (es) Compuestos pirazólicos 436
UY32674A (es) Derivados heterociclicos de la urea y sus metodos de empleo
UY32856A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
UY32694A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
UY32316A (es) Derivados de piperidina utiles en el tratamiento de infecciones bacterianas
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos
UY32247A (es) Nuevos compuestos de aminociclohexilo, composiciones farmacéuticas de los mismos y aplicaciones
UY31805A (es) Agonistas m1, composiciones farmacéuticas de los mismos, procesos para su preparacion y sus usos para el tratamiento del dolor

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20130124